This medical health video focus' on how to survive pancreatic cancer.
Read the full transcript »
Jennifer Matthews: Last December, Arnold Wroblewski joined the 30,000 people diagnosed with pancreatic cancer each year. Arnold Wroblewski: It took quite a while for it to soak in that this was really what's happening. Jennifer Matthews: Facing a grim diagnosis, he enrolled in a study on an experimental treatment for the disease. Dr. Kenneth Chang: It's a new paradigm in cancer treatment. The concept is very new, very cutting edge, and very exciting. Jennifer Matthews: That concept is this drug -- TNF-Erade. TNF is a cancer-fighter that occurs naturally in the body. Doctors inject the gene for TNF into the tumor to capitalize on its cancer-killing ability. It works in synergy with radiation and chemotherapy. Chemo makes radiation more effective and radiation makes TNF multiply faster. Dr. Kenneth Chang: This represents a potential to truly advance our ability to treat and potentially cure cancers as lethal as pancreatic cancer. Jennifer Matthews: Early results show 33 percent of patients who received the highest dose had their tumors shrink more than 50 percent. Nearly one year later, Arnold's tumor is gone. Dr. Kenneth Chang: He should have, by all statistics, been dead at this time, but he is alive. He is well. He is fully functioning. Arnold Wroblewski: There's still something special that I need to get done to help some other less fortunate people in the world, because I've been so fortunate, so fortunate, and I can't believe why. Jennifer Matthews: This is Jennifer Matthews reporting.